The Subject Of Performance Are Continuous Deliveries Of A Medicinal Product With The Active Substance Ravulizumab In The Composition And Expected Quantity Specified In Annex No 5 To This Tender Dossier Annex No 5 Also Contains The Technical Specification Of The Subject Of Performance The Quantity Of The Subject Of Performance Stated In Annex No 5 Is An Approximate Quantity The Contracting Authority Is Entitled To Determine The Specific Quantity And Time Of Performance Of Individual Parts
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
